Phase II trials of malignant mesothelioma: A commentary and update
- 30 September 1994
- journal article
- editorial
- Published by Elsevier in Lung Cancer
- Vol. 11 (3) , 305-308
- https://doi.org/10.1016/0169-5002(94)90551-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Combination chemotherapy with cisplatin-vinblastine in malignant mesotheliomaLung Cancer, 1994
- High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four casesLung Cancer, 1994
- A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesotheliomaAnnals of Oncology, 1994
- A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group studyCancer, 1992
- Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesotheliomaZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Treatment of malignant mesothelioma with epirubicin and ifosfamide: A phase II cooperative studyAnnals of Oncology, 1992
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991
- Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II studyCancer, 1991
- Chemotherapy in malignant mesothelioma: a reviewCancer Chemotherapy and Pharmacology, 1991
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976